nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Niacin—atherosclerosis	0.11	0.169	CbGbCtD
Hydrocodone—CYP2D6—Simvastatin—atherosclerosis	0.0873	0.134	CbGbCtD
Hydrocodone—CYP2D6—Pravastatin—atherosclerosis	0.0854	0.131	CbGbCtD
Hydrocodone—CYP2D6—Lovastatin—atherosclerosis	0.0854	0.131	CbGbCtD
Hydrocodone—CYP3A4—Rosuvastatin—atherosclerosis	0.0597	0.0916	CbGbCtD
Hydrocodone—CYP3A4—Ezetimibe—atherosclerosis	0.0597	0.0916	CbGbCtD
Hydrocodone—CYP3A4—Simvastatin—atherosclerosis	0.0555	0.0851	CbGbCtD
Hydrocodone—CYP3A4—Lovastatin—atherosclerosis	0.0543	0.0833	CbGbCtD
Hydrocodone—CYP3A4—Pravastatin—atherosclerosis	0.0543	0.0833	CbGbCtD
Hydrocodone—Drug interaction—Rosuvastatin—atherosclerosis	0.00433	0.0183	CcSEcCtD
Hydrocodone—Naloxone—TLR4—atherosclerosis	0.0037	0.712	CrCbGaD
Hydrocodone—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.0037	0.0156	CcSEcCtD
Hydrocodone—Drug interaction—Ezetimibe—atherosclerosis	0.0036	0.0152	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00344	0.0145	CcSEcCtD
Hydrocodone—Drug interaction—Simvastatin—atherosclerosis	0.00343	0.0145	CcSEcCtD
Hydrocodone—Neck pain—Ezetimibe—atherosclerosis	0.00338	0.0142	CcSEcCtD
Hydrocodone—Drug interaction—Pravastatin—atherosclerosis	0.0031	0.0131	CcSEcCtD
Hydrocodone—Hearing impaired—Pravastatin—atherosclerosis	0.00302	0.0127	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00291	0.0123	CcSEcCtD
Hydrocodone—Hot flush—Ezetimibe—atherosclerosis	0.00259	0.0109	CcSEcCtD
Hydrocodone—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00257	0.0108	CcSEcCtD
Hydrocodone—Pain in extremity—Lovastatin—atherosclerosis	0.00247	0.0104	CcSEcCtD
Hydrocodone—Pain in extremity—Ezetimibe—atherosclerosis	0.00242	0.0102	CcSEcCtD
Hydrocodone—Deafness—Pravastatin—atherosclerosis	0.00234	0.00985	CcSEcCtD
Hydrocodone—Hot flush—Pravastatin—atherosclerosis	0.00223	0.00942	CcSEcCtD
Hydrocodone—Menopausal symptoms—Pravastatin—atherosclerosis	0.00221	0.00934	CcSEcCtD
Hydrocodone—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00218	0.00921	CcSEcCtD
Hydrocodone—Migraine—Niacin—atherosclerosis	0.00209	0.00881	CcSEcCtD
Hydrocodone—Affect lability—Pravastatin—atherosclerosis	0.00206	0.00867	CcSEcCtD
Hydrocodone—Abdominal discomfort—Lovastatin—atherosclerosis	0.00205	0.00863	CcSEcCtD
Hydrocodone—Urinary retention—Niacin—atherosclerosis	0.00202	0.00851	CcSEcCtD
Hydrocodone—Mood swings—Pravastatin—atherosclerosis	0.00198	0.00834	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00195	0.00821	CcSEcCtD
Hydrocodone—Abdominal discomfort—Simvastatin—atherosclerosis	0.00191	0.00807	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00186	0.00783	CcSEcCtD
Hydrocodone—Urinary tract infection—Lovastatin—atherosclerosis	0.00185	0.0078	CcSEcCtD
Hydrocodone—Mental disorder—Rosuvastatin—atherosclerosis	0.00177	0.00745	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00168	0.00708	CcSEcCtD
Hydrocodone—Oedema peripheral—Ezetimibe—atherosclerosis	0.00165	0.00696	CcSEcCtD
Hydrocodone—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00165	0.00695	CcSEcCtD
Hydrocodone—Urinary tract infection—Pravastatin—atherosclerosis	0.00156	0.0066	CcSEcCtD
Hydrocodone—Cough—Rosuvastatin—atherosclerosis	0.00153	0.00646	CcSEcCtD
Hydrocodone—Angiopathy—Ezetimibe—atherosclerosis	0.00152	0.00641	CcSEcCtD
Hydrocodone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00151	0.00637	CcSEcCtD
Hydrocodone—Arthralgia—Rosuvastatin—atherosclerosis	0.00149	0.0063	CcSEcCtD
Hydrocodone—Myalgia—Rosuvastatin—atherosclerosis	0.00149	0.0063	CcSEcCtD
Hydrocodone—Mental disorder—Ezetimibe—atherosclerosis	0.00147	0.00619	CcSEcCtD
Hydrocodone—Malnutrition—Ezetimibe—atherosclerosis	0.00146	0.00615	CcSEcCtD
Hydrocodone—Oedema peripheral—Niacin—atherosclerosis	0.00145	0.0061	CcSEcCtD
Hydrocodone—Back pain—Lovastatin—atherosclerosis	0.00144	0.00607	CcSEcCtD
Hydrocodone—Muscle spasms—Lovastatin—atherosclerosis	0.00143	0.00603	CcSEcCtD
Hydrocodone—Back pain—Ezetimibe—atherosclerosis	0.00141	0.00595	CcSEcCtD
Hydrocodone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00141	0.00592	CcSEcCtD
Hydrocodone—Muscle spasms—Ezetimibe—atherosclerosis	0.0014	0.00592	CcSEcCtD
Hydrocodone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.0014	0.00591	CcSEcCtD
Hydrocodone—Mental disorder—Simvastatin—atherosclerosis	0.0014	0.00591	CcSEcCtD
Hydrocodone—Tremor—Lovastatin—atherosclerosis	0.00139	0.00588	CcSEcCtD
Hydrocodone—Muscle spasms—Simvastatin—atherosclerosis	0.00134	0.00564	CcSEcCtD
Hydrocodone—Angiopathy—Niacin—atherosclerosis	0.00133	0.00562	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00131	0.0055	CcSEcCtD
Hydrocodone—Tremor—Simvastatin—atherosclerosis	0.0013	0.0055	CcSEcCtD
Hydrocodone—Insomnia—Rosuvastatin—atherosclerosis	0.0013	0.00546	CcSEcCtD
Hydrocodone—Paraesthesia—Rosuvastatin—atherosclerosis	0.00129	0.00542	CcSEcCtD
Hydrocodone—Malnutrition—Niacin—atherosclerosis	0.00128	0.00539	CcSEcCtD
Hydrocodone—Cough—Ezetimibe—atherosclerosis	0.00127	0.00537	CcSEcCtD
Hydrocodone—Myalgia—Lovastatin—atherosclerosis	0.00127	0.00534	CcSEcCtD
Hydrocodone—Arthralgia—Lovastatin—atherosclerosis	0.00127	0.00534	CcSEcCtD
Hydrocodone—Anxiety—Lovastatin—atherosclerosis	0.00126	0.00532	CcSEcCtD
Hydrocodone—Myalgia—Ezetimibe—atherosclerosis	0.00124	0.00524	CcSEcCtD
Hydrocodone—Arthralgia—Ezetimibe—atherosclerosis	0.00124	0.00524	CcSEcCtD
Hydrocodone—Dry mouth—Lovastatin—atherosclerosis	0.00124	0.00522	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00123	0.0052	CcSEcCtD
Hydrocodone—Muscle spasms—Niacin—atherosclerosis	0.00123	0.00518	CcSEcCtD
Hydrocodone—Constipation—Rosuvastatin—atherosclerosis	0.00123	0.00517	CcSEcCtD
Hydrocodone—Dry mouth—Ezetimibe—atherosclerosis	0.00121	0.00512	CcSEcCtD
Hydrocodone—Muscle spasms—Pravastatin—atherosclerosis	0.00121	0.0051	CcSEcCtD
Hydrocodone—Thrombocytopenia—Lovastatin—atherosclerosis	0.00119	0.00501	CcSEcCtD
Hydrocodone—Arthralgia—Simvastatin—atherosclerosis	0.00118	0.005	CcSEcCtD
Hydrocodone—Myalgia—Simvastatin—atherosclerosis	0.00118	0.005	CcSEcCtD
Hydrocodone—Anxiety—Simvastatin—atherosclerosis	0.00118	0.00498	CcSEcCtD
Hydrocodone—Tremor—Pravastatin—atherosclerosis	0.00118	0.00497	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00117	0.00494	CcSEcCtD
Hydrocodone—Nervous system disorder—Ezetimibe—atherosclerosis	0.00117	0.00492	CcSEcCtD
Hydrocodone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00117	0.00492	CcSEcCtD
Hydrocodone—Skin disorder—Ezetimibe—atherosclerosis	0.00116	0.00488	CcSEcCtD
Hydrocodone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00113	0.00478	CcSEcCtD
Hydrocodone—Cough—Niacin—atherosclerosis	0.00111	0.0047	CcSEcCtD
Hydrocodone—Thrombocytopenia—Simvastatin—atherosclerosis	0.00111	0.00469	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00111	0.00466	CcSEcCtD
Hydrocodone—Insomnia—Lovastatin—atherosclerosis	0.0011	0.00463	CcSEcCtD
Hydrocodone—Cough—Pravastatin—atherosclerosis	0.0011	0.00463	CcSEcCtD
Hydrocodone—Paraesthesia—Lovastatin—atherosclerosis	0.00109	0.0046	CcSEcCtD
Hydrocodone—Arthralgia—Niacin—atherosclerosis	0.00109	0.00459	CcSEcCtD
Hydrocodone—Myalgia—Niacin—atherosclerosis	0.00109	0.00459	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00108	0.00457	CcSEcCtD
Hydrocodone—Dyspnoea—Lovastatin—atherosclerosis	0.00108	0.00456	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00108	0.00456	CcSEcCtD
Hydrocodone—Insomnia—Ezetimibe—atherosclerosis	0.00108	0.00454	CcSEcCtD
Hydrocodone—Arthralgia—Pravastatin—atherosclerosis	0.00107	0.00452	CcSEcCtD
Hydrocodone—Myalgia—Pravastatin—atherosclerosis	0.00107	0.00452	CcSEcCtD
Hydrocodone—Paraesthesia—Ezetimibe—atherosclerosis	0.00107	0.00451	CcSEcCtD
Hydrocodone—Anxiety—Pravastatin—atherosclerosis	0.00107	0.0045	CcSEcCtD
Hydrocodone—Dry mouth—Niacin—atherosclerosis	0.00106	0.00449	CcSEcCtD
Hydrocodone—Dyspnoea—Ezetimibe—atherosclerosis	0.00106	0.00448	CcSEcCtD
Hydrocodone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00106	0.00445	CcSEcCtD
Hydrocodone—Fatigue—Lovastatin—atherosclerosis	0.00105	0.00441	CcSEcCtD
Hydrocodone—Naloxone—ESR1—atherosclerosis	0.00104	0.2	CrCbGaD
Hydrocodone—Constipation—Lovastatin—atherosclerosis	0.00104	0.00438	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00103	0.00436	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00103	0.00434	CcSEcCtD
Hydrocodone—Asthenia—Rosuvastatin—atherosclerosis	0.00103	0.00433	CcSEcCtD
Hydrocodone—Insomnia—Simvastatin—atherosclerosis	0.00103	0.00433	CcSEcCtD
Hydrocodone—Fatigue—Ezetimibe—atherosclerosis	0.00103	0.00433	CcSEcCtD
Hydrocodone—Paraesthesia—Simvastatin—atherosclerosis	0.00102	0.0043	CcSEcCtD
Hydrocodone—Constipation—Ezetimibe—atherosclerosis	0.00102	0.00429	CcSEcCtD
Hydrocodone—Pruritus—Rosuvastatin—atherosclerosis	0.00101	0.00427	CcSEcCtD
Hydrocodone—Skin disorder—Niacin—atherosclerosis	0.00101	0.00427	CcSEcCtD
Hydrocodone—Dyspnoea—Simvastatin—atherosclerosis	0.00101	0.00427	CcSEcCtD
Hydrocodone—Hyperhidrosis—Niacin—atherosclerosis	0.00101	0.00425	CcSEcCtD
Hydrocodone—Thrombocytopenia—Pravastatin—atherosclerosis	0.00101	0.00424	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000993	0.00419	CcSEcCtD
Hydrocodone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000993	0.00419	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00098	0.00413	CcSEcCtD
Hydrocodone—Fatigue—Simvastatin—atherosclerosis	0.000979	0.00413	CcSEcCtD
Hydrocodone—Hypotension—Niacin—atherosclerosis	0.000974	0.00411	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000974	0.00411	CcSEcCtD
Hydrocodone—Constipation—Simvastatin—atherosclerosis	0.000971	0.0041	CcSEcCtD
Hydrocodone—Abdominal pain—Lovastatin—atherosclerosis	0.00096	0.00405	CcSEcCtD
Hydrocodone—Body temperature increased—Lovastatin—atherosclerosis	0.00096	0.00405	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00095	0.00401	CcSEcCtD
Hydrocodone—Dizziness—Rosuvastatin—atherosclerosis	0.000947	0.00399	CcSEcCtD
Hydrocodone—Insomnia—Niacin—atherosclerosis	0.000943	0.00398	CcSEcCtD
Hydrocodone—Abdominal pain—Ezetimibe—atherosclerosis	0.000941	0.00397	CcSEcCtD
Hydrocodone—Body temperature increased—Ezetimibe—atherosclerosis	0.000941	0.00397	CcSEcCtD
Hydrocodone—Paraesthesia—Niacin—atherosclerosis	0.000936	0.00395	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000935	0.00394	CcSEcCtD
Hydrocodone—Dyspnoea—Niacin—atherosclerosis	0.00093	0.00392	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000929	0.00392	CcSEcCtD
Hydrocodone—Insomnia—Pravastatin—atherosclerosis	0.000929	0.00392	CcSEcCtD
Hydrocodone—Somnolence—Niacin—atherosclerosis	0.000927	0.00391	CcSEcCtD
Hydrocodone—Paraesthesia—Pravastatin—atherosclerosis	0.000922	0.00389	CcSEcCtD
Hydrocodone—Dyspnoea—Pravastatin—atherosclerosis	0.000915	0.00386	CcSEcCtD
Hydrocodone—Rash—Rosuvastatin—atherosclerosis	0.000903	0.00381	CcSEcCtD
Hydrocodone—Dermatitis—Rosuvastatin—atherosclerosis	0.000903	0.00381	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Niacin—atherosclerosis	0.0009	0.0038	CcSEcCtD
Hydrocodone—Abdominal pain—Simvastatin—atherosclerosis	0.000898	0.00379	CcSEcCtD
Hydrocodone—Body temperature increased—Simvastatin—atherosclerosis	0.000898	0.00379	CcSEcCtD
Hydrocodone—Headache—Rosuvastatin—atherosclerosis	0.000898	0.00378	CcSEcCtD
Hydrocodone—Hypersensitivity—Lovastatin—atherosclerosis	0.000895	0.00377	CcSEcCtD
Hydrocodone—Fatigue—Pravastatin—atherosclerosis	0.000885	0.00373	CcSEcCtD
Hydrocodone—Constipation—Pravastatin—atherosclerosis	0.000878	0.0037	CcSEcCtD
Hydrocodone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000877	0.0037	CcSEcCtD
Hydrocodone—Asthenia—Lovastatin—atherosclerosis	0.000871	0.00367	CcSEcCtD
Hydrocodone—Pruritus—Lovastatin—atherosclerosis	0.000859	0.00362	CcSEcCtD
Hydrocodone—Asthenia—Ezetimibe—atherosclerosis	0.000854	0.0036	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Niacin—atherosclerosis	0.000853	0.0036	CcSEcCtD
Hydrocodone—Nausea—Rosuvastatin—atherosclerosis	0.000851	0.00359	CcSEcCtD
Hydrocodone—Pruritus—Ezetimibe—atherosclerosis	0.000843	0.00355	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00084	0.00354	CcSEcCtD
Hydrocodone—Hypersensitivity—Simvastatin—atherosclerosis	0.000837	0.00353	CcSEcCtD
Hydrocodone—Abdominal pain—Niacin—atherosclerosis	0.000824	0.00348	CcSEcCtD
Hydrocodone—Body temperature increased—Niacin—atherosclerosis	0.000824	0.00348	CcSEcCtD
Hydrocodone—Asthenia—Simvastatin—atherosclerosis	0.000815	0.00344	CcSEcCtD
Hydrocodone—Body temperature increased—Pravastatin—atherosclerosis	0.000812	0.00342	CcSEcCtD
Hydrocodone—Abdominal pain—Pravastatin—atherosclerosis	0.000812	0.00342	CcSEcCtD
Hydrocodone—Pruritus—Simvastatin—atherosclerosis	0.000803	0.00339	CcSEcCtD
Hydrocodone—Dizziness—Lovastatin—atherosclerosis	0.000803	0.00339	CcSEcCtD
Hydrocodone—Dizziness—Ezetimibe—atherosclerosis	0.000788	0.00332	CcSEcCtD
Hydrocodone—Vomiting—Lovastatin—atherosclerosis	0.000772	0.00326	CcSEcCtD
Hydrocodone—Hypersensitivity—Niacin—atherosclerosis	0.000768	0.00324	CcSEcCtD
Hydrocodone—Rash—Lovastatin—atherosclerosis	0.000766	0.00323	CcSEcCtD
Hydrocodone—Dermatitis—Lovastatin—atherosclerosis	0.000765	0.00323	CcSEcCtD
Hydrocodone—Headache—Lovastatin—atherosclerosis	0.000761	0.00321	CcSEcCtD
Hydrocodone—Vomiting—Ezetimibe—atherosclerosis	0.000757	0.00319	CcSEcCtD
Hydrocodone—Hypersensitivity—Pravastatin—atherosclerosis	0.000756	0.00319	CcSEcCtD
Hydrocodone—Dizziness—Simvastatin—atherosclerosis	0.000751	0.00317	CcSEcCtD
Hydrocodone—Rash—Ezetimibe—atherosclerosis	0.000751	0.00317	CcSEcCtD
Hydrocodone—Dermatitis—Ezetimibe—atherosclerosis	0.00075	0.00316	CcSEcCtD
Hydrocodone—Asthenia—Niacin—atherosclerosis	0.000748	0.00315	CcSEcCtD
Hydrocodone—Headache—Ezetimibe—atherosclerosis	0.000746	0.00315	CcSEcCtD
Hydrocodone—Pruritus—Niacin—atherosclerosis	0.000738	0.00311	CcSEcCtD
Hydrocodone—Asthenia—Pravastatin—atherosclerosis	0.000737	0.00311	CcSEcCtD
Hydrocodone—Pruritus—Pravastatin—atherosclerosis	0.000726	0.00306	CcSEcCtD
Hydrocodone—Vomiting—Simvastatin—atherosclerosis	0.000722	0.00304	CcSEcCtD
Hydrocodone—Nausea—Lovastatin—atherosclerosis	0.000721	0.00304	CcSEcCtD
Hydrocodone—Rash—Simvastatin—atherosclerosis	0.000716	0.00302	CcSEcCtD
Hydrocodone—Dermatitis—Simvastatin—atherosclerosis	0.000715	0.00302	CcSEcCtD
Hydrocodone—Headache—Simvastatin—atherosclerosis	0.000711	0.003	CcSEcCtD
Hydrocodone—Nausea—Ezetimibe—atherosclerosis	0.000707	0.00298	CcSEcCtD
Hydrocodone—Dizziness—Niacin—atherosclerosis	0.00069	0.00291	CcSEcCtD
Hydrocodone—Dizziness—Pravastatin—atherosclerosis	0.000679	0.00286	CcSEcCtD
Hydrocodone—Nausea—Simvastatin—atherosclerosis	0.000675	0.00284	CcSEcCtD
Hydrocodone—Vomiting—Niacin—atherosclerosis	0.000663	0.0028	CcSEcCtD
Hydrocodone—Rash—Niacin—atherosclerosis	0.000658	0.00277	CcSEcCtD
Hydrocodone—Dermatitis—Niacin—atherosclerosis	0.000657	0.00277	CcSEcCtD
Hydrocodone—Headache—Niacin—atherosclerosis	0.000653	0.00275	CcSEcCtD
Hydrocodone—Vomiting—Pravastatin—atherosclerosis	0.000653	0.00275	CcSEcCtD
Hydrocodone—Rash—Pravastatin—atherosclerosis	0.000647	0.00273	CcSEcCtD
Hydrocodone—Dermatitis—Pravastatin—atherosclerosis	0.000647	0.00273	CcSEcCtD
Hydrocodone—Headache—Pravastatin—atherosclerosis	0.000643	0.00271	CcSEcCtD
Hydrocodone—Nausea—Niacin—atherosclerosis	0.000619	0.00261	CcSEcCtD
Hydrocodone—Nausea—Pravastatin—atherosclerosis	0.00061	0.00257	CcSEcCtD
Hydrocodone—Naloxone—ALB—atherosclerosis	0.000463	0.0888	CrCbGaD
Hydrocodone—OPRK1—GPCR downstream signaling—F2—atherosclerosis	5.41e-05	0.000513	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	5.38e-05	0.00051	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CG—atherosclerosis	5.37e-05	0.000509	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AGT—atherosclerosis	5.32e-05	0.000505	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EDNRA—atherosclerosis	5.25e-05	0.000498	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR2—atherosclerosis	5.25e-05	0.000498	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CYBA—atherosclerosis	5.23e-05	0.000496	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CG—atherosclerosis	5.18e-05	0.000491	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KNG1—atherosclerosis	5.12e-05	0.000486	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PARP1—atherosclerosis	5.12e-05	0.000485	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PLAT—atherosclerosis	5.12e-05	0.000485	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GHRL—atherosclerosis	5.12e-05	0.000485	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	5.11e-05	0.000485	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AGTR1—atherosclerosis	5.09e-05	0.000483	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VWF—atherosclerosis	5.09e-05	0.000483	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOC3—atherosclerosis	5.06e-05	0.00048	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LDLR—atherosclerosis	5.03e-05	0.000477	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL2—atherosclerosis	5e-05	0.000474	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PLG—atherosclerosis	4.96e-05	0.000471	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	4.95e-05	0.00047	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—F2—atherosclerosis	4.92e-05	0.000466	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL3—atherosclerosis	4.91e-05	0.000466	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CG—atherosclerosis	4.7e-05	0.000446	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NCF1—atherosclerosis	4.7e-05	0.000446	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SOCS3—atherosclerosis	4.7e-05	0.000446	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—F2—atherosclerosis	4.58e-05	0.000434	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP3—atherosclerosis	4.54e-05	0.000431	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	4.53e-05	0.00043	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF2—atherosclerosis	4.52e-05	0.000429	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AGT—atherosclerosis	4.5e-05	0.000426	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KNG1—atherosclerosis	4.49e-05	0.000426	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCG1—atherosclerosis	4.47e-05	0.000424	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGTR1—atherosclerosis	4.47e-05	0.000424	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR2—atherosclerosis	4.44e-05	0.000421	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	4.44e-05	0.000421	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CYBA—atherosclerosis	4.42e-05	0.000419	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOB—atherosclerosis	4.39e-05	0.000416	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL2—atherosclerosis	4.38e-05	0.000416	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	4.38e-05	0.000415	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PLG—atherosclerosis	4.35e-05	0.000413	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL8—atherosclerosis	4.35e-05	0.000413	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GHRL—atherosclerosis	4.33e-05	0.00041	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PARP1—atherosclerosis	4.33e-05	0.00041	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PLAT—atherosclerosis	4.33e-05	0.00041	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EDN1—atherosclerosis	4.32e-05	0.00041	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL5—atherosclerosis	4.28e-05	0.000406	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLTP—atherosclerosis	4.26e-05	0.000404	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—FABP4—atherosclerosis	4.2e-05	0.000398	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LCAT—atherosclerosis	4.2e-05	0.000398	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LPL—atherosclerosis	4.19e-05	0.000397	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—F2—atherosclerosis	4.15e-05	0.000394	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA4—atherosclerosis	4.12e-05	0.000391	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	4.12e-05	0.000391	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	4.07e-05	0.000386	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP7A1—atherosclerosis	4.05e-05	0.000384	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP3—atherosclerosis	3.98e-05	0.000378	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	3.98e-05	0.000377	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SPP1—atherosclerosis	3.97e-05	0.000376	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF2—atherosclerosis	3.96e-05	0.000376	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	3.95e-05	0.000375	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOB—atherosclerosis	3.85e-05	0.000365	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	3.81e-05	0.000362	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KNG1—atherosclerosis	3.8e-05	0.00036	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EDN1—atherosclerosis	3.79e-05	0.000359	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	3.77e-05	0.000358	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL5—atherosclerosis	3.76e-05	0.000356	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP27A1—atherosclerosis	3.74e-05	0.000355	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	3.7e-05	0.000351	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.7e-05	0.00035	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.7e-05	0.00035	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PLG—atherosclerosis	3.68e-05	0.000349	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LPL—atherosclerosis	3.67e-05	0.000348	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	3.67e-05	0.000348	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AGT—atherosclerosis	3.58e-05	0.00034	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	3.57e-05	0.000339	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	3.55e-05	0.000337	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALOX15—atherosclerosis	3.55e-05	0.000337	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	3.55e-05	0.000337	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA2—atherosclerosis	3.55e-05	0.000337	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LEP—atherosclerosis	3.51e-05	0.000333	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOE—atherosclerosis	3.51e-05	0.000333	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCG5—atherosclerosis	3.51e-05	0.000332	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	3.48e-05	0.00033	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SPP1—atherosclerosis	3.48e-05	0.00033	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CAV1—atherosclerosis	3.48e-05	0.00033	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOA1—atherosclerosis	3.47e-05	0.000329	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	3.46e-05	0.000329	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LPA—atherosclerosis	3.39e-05	0.000321	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP3—atherosclerosis	3.36e-05	0.000319	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ESR1—atherosclerosis	3.35e-05	0.000318	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF2—atherosclerosis	3.35e-05	0.000318	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—F2—atherosclerosis	3.31e-05	0.000314	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—BGN—atherosclerosis	3.28e-05	0.000311	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOB—atherosclerosis	3.25e-05	0.000308	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA5—atherosclerosis	3.25e-05	0.000308	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	3.22e-05	0.000306	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	3.22e-05	0.000305	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDN1—atherosclerosis	3.2e-05	0.000303	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL5—atherosclerosis	3.18e-05	0.000301	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	3.17e-05	0.000301	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGT—atherosclerosis	3.14e-05	0.000298	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	3.12e-05	0.000296	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LPL—atherosclerosis	3.1e-05	0.000294	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LEP—atherosclerosis	3.08e-05	0.000292	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOE—atherosclerosis	3.08e-05	0.000292	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CAV1—atherosclerosis	3.05e-05	0.000289	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOA1—atherosclerosis	3.04e-05	0.000289	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	3.04e-05	0.000288	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	3.02e-05	0.000286	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALOX5—atherosclerosis	3.02e-05	0.000286	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—INS—atherosclerosis	3e-05	0.000285	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL2—atherosclerosis	2.95e-05	0.00028	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SPP1—atherosclerosis	2.94e-05	0.000279	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ESR1—atherosclerosis	2.94e-05	0.000279	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	2.93e-05	0.000278	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.92e-05	0.000277	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—F2—atherosclerosis	2.9e-05	0.000275	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1—atherosclerosis	2.9e-05	0.000275	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	2.78e-05	0.000264	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	2.76e-05	0.000261	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—FABP4—atherosclerosis	2.75e-05	0.00026	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LCAT—atherosclerosis	2.75e-05	0.00026	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	2.72e-05	0.000258	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.71e-05	0.000257	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA4—atherosclerosis	2.7e-05	0.000256	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LIPC—atherosclerosis	2.69e-05	0.000255	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOC3—atherosclerosis	2.67e-05	0.000254	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	2.66e-05	0.000252	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LDLR—atherosclerosis	2.66e-05	0.000252	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGT—atherosclerosis	2.66e-05	0.000252	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.65e-05	0.000251	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOS3—atherosclerosis	2.63e-05	0.00025	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INS—atherosclerosis	2.63e-05	0.000249	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOE—atherosclerosis	2.6e-05	0.000247	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—atherosclerosis	2.6e-05	0.000247	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CETP—atherosclerosis	2.6e-05	0.000246	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL2—atherosclerosis	2.59e-05	0.000245	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CAV1—atherosclerosis	2.58e-05	0.000245	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOA1—atherosclerosis	2.57e-05	0.000244	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—atherosclerosis	2.54e-05	0.000241	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.49e-05	0.000236	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—atherosclerosis	2.48e-05	0.000236	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—F2—atherosclerosis	2.45e-05	0.000233	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.45e-05	0.000232	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	2.42e-05	0.000229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	2.35e-05	0.000223	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.35e-05	0.000223	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	2.33e-05	0.000221	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.32e-05	0.00022	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.32e-05	0.00022	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA2—atherosclerosis	2.32e-05	0.00022	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.32e-05	0.00022	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOS3—atherosclerosis	2.31e-05	0.000219	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.29e-05	0.000217	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	2.25e-05	0.000214	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	2.25e-05	0.000213	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INS—atherosclerosis	2.22e-05	0.000211	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—atherosclerosis	2.22e-05	0.00021	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPA—atherosclerosis	2.21e-05	0.00021	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL2—atherosclerosis	2.19e-05	0.000207	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—atherosclerosis	2.15e-05	0.000204	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—BGN—atherosclerosis	2.14e-05	0.000203	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA5—atherosclerosis	2.12e-05	0.000201	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—atherosclerosis	2.11e-05	0.0002	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.09e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	2.09e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	2.05e-05	0.000195	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	2.05e-05	0.000194	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	2.05e-05	0.000194	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.04e-05	0.000194	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	2.04e-05	0.000194	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	1.98e-05	0.000187	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.97e-05	0.000187	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOS3—atherosclerosis	1.95e-05	0.000185	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—atherosclerosis	1.95e-05	0.000185	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	1.9e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—atherosclerosis	1.88e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—atherosclerosis	1.85e-05	0.000176	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	1.83e-05	0.000174	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	1.8e-05	0.000171	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	1.8e-05	0.00017	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.79e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	1.79e-05	0.00017	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.77e-05	0.000168	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LIPC—atherosclerosis	1.76e-05	0.000167	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOC3—atherosclerosis	1.75e-05	0.000166	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	1.74e-05	0.000165	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LDLR—atherosclerosis	1.74e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	1.73e-05	0.000164	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOB—atherosclerosis	1.72e-05	0.000163	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CETP—atherosclerosis	1.7e-05	0.000161	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.67e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.67e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	1.66e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—atherosclerosis	1.65e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—atherosclerosis	1.64e-05	0.000156	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LPL—atherosclerosis	1.64e-05	0.000156	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.62e-05	0.000154	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX1—atherosclerosis	1.6e-05	0.000152	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	1.57e-05	0.000149	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—atherosclerosis	1.56e-05	0.000148	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CD36—atherosclerosis	1.56e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	1.55e-05	0.000147	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.53e-05	0.000146	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	1.53e-05	0.000145	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	1.52e-05	0.000144	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	1.52e-05	0.000144	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.48e-05	0.00014	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARA—atherosclerosis	1.45e-05	0.000138	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	1.4e-05	0.000133	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AGT—atherosclerosis	1.4e-05	0.000133	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOE—atherosclerosis	1.38e-05	0.00013	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.37e-05	0.00013	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CAV1—atherosclerosis	1.36e-05	0.000129	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA1—atherosclerosis	1.36e-05	0.000129	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	1.33e-05	0.000126	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—atherosclerosis	1.31e-05	0.000124	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	1.29e-05	0.000122	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—atherosclerosis	1.21e-05	0.000115	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARG—atherosclerosis	1.2e-05	0.000114	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—INS—atherosclerosis	1.18e-05	0.000111	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.17e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—atherosclerosis	1.15e-05	0.000109	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOB—atherosclerosis	1.12e-05	0.000107	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.09e-05	0.000104	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—atherosclerosis	1.08e-05	0.000102	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPL—atherosclerosis	1.07e-05	0.000102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—atherosclerosis	1.06e-05	0.000101	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX1—atherosclerosis	1.05e-05	9.93e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NOS3—atherosclerosis	1.03e-05	9.78e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CD36—atherosclerosis	1.02e-05	9.67e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—atherosclerosis	9.72e-06	9.21e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—atherosclerosis	9.66e-06	9.16e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARA—atherosclerosis	9.48e-06	8.99e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—atherosclerosis	9.43e-06	8.94e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AGT—atherosclerosis	9.18e-06	8.71e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOE—atherosclerosis	9e-06	8.53e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—atherosclerosis	8.96e-06	8.5e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CAV1—atherosclerosis	8.91e-06	8.45e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA1—atherosclerosis	8.89e-06	8.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	8.12e-06	7.7e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARG—atherosclerosis	7.84e-06	7.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—INS—atherosclerosis	7.69e-06	7.29e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—atherosclerosis	7.05e-06	6.68e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NOS3—atherosclerosis	6.74e-06	6.39e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—atherosclerosis	6.16e-06	5.85e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—atherosclerosis	4.74e-06	4.49e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—atherosclerosis	3.1e-06	2.94e-05	CbGpPWpGaD
